Moreover, L-pimaric acid could induce the death of drug-resistant lung cancer cells by downregulating Bcl-2, upregulating Bax, activating the p38 MAPK/JNK signaling pathways, and inhibiting the ERK pathway. This evidence concerns the gene BCL2 and lung carcinoma.